Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04116775 |
|
Recruitment Status :
Recruiting
First Posted : October 7, 2019
Last Update Posted : June 23, 2022
|
Sponsor:
Julie Graff, MD
Collaborators:
Merck Sharp & Dohme LLC
Prostate Cancer Foundation
Johns Hopkins University
Oregon Health and Science University
Information provided by (Responsible Party):
Julie Graff, MD, Portland VA Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2023 |
| Estimated Study Completion Date : | October 2023 |